November 14, 2016 / 11:57 AM / in a year

BRIEF-Prometic life sciences PBI-4050 shown to reduce pulmonary hypertension

Nov 14 (Reuters) - Prometic Life Sciences Inc :

* Prometic Life Sciences - PBI-4050 shown to reduce pulmonary hypertension and lung remodeling and to improve right ventricular function in heart failure

* Prometic Life Sciences - PBI-4050 did not adversely affect healing of left ventricle, observed some improvement in left ventricular function Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below